Proof Capital Medical Receivables Yield Fund

The Proof Capital Medical Receivables Yield Fund provides access to a specialized alternative asset strategy focused on American personal injury medical receivables. The Fund supplies capital to medical providers while they await settlement of eligible receivables, seeking to generate returns through a combination of conventional lending and profit-sharing arrangements. Its investment approach combines opportunistic investing with fixed-income characteristics, targeting attractive risk-adjusted returns from a less traditional segment of the private credit market.

Targeted Net Returns:

The Fund targets a net annualized return of 11–15%, although returns are not guaranteed. 

Specialized Alternative Asset Exposure:

Access to the U.S. personal injury medical receivables market. 

Multiple Return Drivers:

The conventional loan book targets approximately 17–20% annually, while the profit-share book targets approximately 20–30%+ at the underlying investment level. 

Diversification:

Exposure to an alternative strategy outside traditional equities and fixed income markets.

Open-Ended Structure:

The Fund is open-ended, while underlying investments generally have an anticipated repayment cycle of approximately 1.5 to 2.5 years. 

Opportunistic + Income Strategy:

Combines fixed-income-style lending with opportunistic profit-sharing investments.

The Fund invests primarily in American personal injury medical receivables through conventional loans and profit-sharing investments. Capital is provided to medical providers seeking liquidity while awaiting payment or settlement of outstanding receivables. The strategy is designed to capitalize on the financing gap between the delivery of medical services and the eventual collection of receivables, generating returns through interest income and participation in receivable proceeds.